For example, TRIM47, TRIM27, UBR5, and FBXW2 can regulate breast cancer progression and endocrine therapy sensitivities via the polyubiquitination of PKC‐ε, P21, β‐catenin, and MSX2, respectively.[41]. This evidence concerns the gene MSX2 and breast carcinoma.